Willingness to pay for allergy-vaccination among Danish patients with respiratory allergy

International Journal of Technology Assessment in Health Care

Volumn 26, Issue 1, 2010, Pages 20-29

  Petersen, Karin Dam ^a   Gyrd Hansen, Dorte ^a   Linneberg, Allan ^b   Dahl, Ronald ^c   Larsen, Jrgen Nedergaard ^d   Løwenstein, Henning ^d   Kronborg, Christian ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d ALK Abell ^*  (Denmark)

Author keywords

Allergic rhinoconjunctivitis; Allergy specific subcutaneous injection immunotherapy (SCIT); EQ 5D; Quality adjusted life years (QALY); Willingness to pay (WTP)

Indexed keywords

CLASSIFICATION ,; CONFIDENCE LIMIT; DISCRETE CHOICE; EQ-5D; GENERAL POPULATION; GENERAL PRACTITIONERS; QUALITY-ADJUSTED LIFE YEARS; RANDOM SAMPLE; WILLINGNESS TO PAY;

ALLERGIES;

ALLERGEN;

ADULT; AGED; ARTICLE; ASTHMA; COHORT ANALYSIS; DEMOGRAPHY; DISEASE SEVERITY; FEMALE; HUMAN; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; OPEN ENDED QUESTIONNAIRE; PATIENT PARTICIPATION; PATIENT SELECTION; QUALITY ADJUSTED LIFE YEAR; RANDOM SAMPLE; RESPIRATORY TRACT ALLERGY; RHINOCONJUNCTIVITIS; SELF REPORT; VACCINATION; ADOLESCENT; AGE; DENMARK; DESENSITIZATION; ECONOMICS; HOSPITALIZATION; IMMUNOLOGY; MIDDLE AGED; PATIENT ATTITUDE; PERENNIAL RHINITIS; SEX DIFFERENCE; SOCIOECONOMICS; SUBCUTANEOUS DRUG ADMINISTRATION;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ASTHMA; COHORT STUDIES; DENMARK; DESENSITIZATION, IMMUNOLOGIC; FEMALE; HUMANS; INJECTIONS, SUBCUTANEOUS; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; QUALITY-ADJUSTED LIFE YEARS; RHINITIS, ALLERGIC, PERENNIAL; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SOCIOECONOMIC FACTORS; YOUNG ADULT;

EID: 77949889478     PISSN: 02664623     EISSN: 14716348     Source Type: Journal    
DOI: 10.1017/S026646230999081X     Document Type: Article

References (25)

1. Ajzen I, Brown TC, Carvajal F. Explaining the discrepancy between intentions and actions: The case of hypothetical bias in contingent valuation. Pers Soc Psychol Bull. 2004;30:1108-1121.
2. Bousquet J,Khaltaev N, Cruz AA, et al.Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update [in collaboration with the World Health Organization, GA(2) LEN and AllerGen]. Allergy. 2008;63(Suppl 86):8-160.
3. Bala MV, Wood LL, Zarkin GA, et al. Valuing outcomes in health care: A comparison of willingness to pay and qualityadjusted life-years. J Clin Epidemiol. 1998;51:667-676.
4. Bateman IJ, Carson RT, Day Brett, et al. Economic valuation with stated preference techniques. A manual. Published for the Department of Transport under license from the Controller of her Majesty's Stationery Office by Edward Elgar Publishing Limited Glensanda House, Montpellier Parade, Cheltenham, Glos GL50 1UA, UK; 2002.
5. Bodtger U, Linneberg A. Remission of allergic rhinitis: An 8-year observational study. J Allergy Clin Immunol. 2004; 114:1384-1388.
6. Bousquet J, Clark TJ, Hurd S, et al. GINA guidelines on asthma and beyond. Allergy. 2007;62:102-112.
7. Calderon MA, Alves B, Jacobson M, et al. Allergen injection immunotherapy for seasonal allergic rhinitis. Cochrane Database Syst Rev. 2007;1:CD001936.
8. Des Roches A, Paradis L, Menardo JL, et al. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children. J Allergy Clin Immunol. 1997;99:450-453.
9. Durham SR, Walker SM, Varga EM, et al. Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med. 1999;341:468-475.
10. Folland S, Goodman AC, Stano M. The economics of health and health care. Oakland: Prentice Hall; 2007.
11. Green WH. Econometric analysis. Englewood Cliffs: Prentice Hall; 1993.
12. Jacobsen L, Niggemann B, Dreborg S, et al. Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy. 2007;62:943-948.
13. Jarvis D, Luczynska C, Chinn S, et al. Change in prevalence of IgE sensitization and mean total IgE with age and cohort. J Allergy Clin Immunol. 2005;116:675-682.
14. Juniper EF, Thompson AK, Ferrie PJ, et al. Validation of the standardized version of the Rhinoconjunctivitis Quality of Life Questionnaire. J Allergy Clin Immunol. 1999;104(pt 1):364-369.
15. Kind P, Dolan P, Gudex C, et al. Variations in population health status: Results from a United Kingdom national questionnaire survey. BMJ. 1998;316:736-741.
16. Koopmanschap MA, Rutten FF, van Ineveld BM, et al. The friction cost method for measuring indirect costs of disease. J Health Econ. 1995;14:171-189.
17. Linneberg A, Gislum M, Johansen N, et al. Temporal trends of aeroallergen sensitization over twenty-five years. Clin Exp Allergy. 2007;37:1137-1142.
18. Linneberg A, Nielsen NH, Madsen F, et al. Increasing prevalence of specific IgE to aeroallergens in an adult population: Two cross-sectional surveys 8 years apart: The Copenhagen Allergy Study. J Allergy Clin Immunol. 2000;106:247-252.
19. Pajno GB, Barberio G, De Luca F, Morabito L, Parmiani S. Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study. Clin Exp Allergy. 2001;31:1392-1397.
20. Pedersen KM,Wittrup-Jensen K, Brooks R, et al. Værdisætning af sundhed. Teorien om kvalitetsjusterede leve°ar og en dansk anvendelse (In Danish: Valuation of health. Theory of quality adjusted life years). Odense: University of Southern Denmark; 2003.
21. Petersen KD, Gyrd-Hansen D, Dahl R. Health-economic analyses of subcutaneous specific immunotherapy for grass pollen and mite allergy. Allergol Immunopathol (Madr). 2005;33:296-302. (Pubitemid 47250520)
22. Petersen KD, Kronborg C, Gyrd-Hansen D, et al. Quality of life in rhinoconjunctivitis assessed with generic and diseasespecific questionnaires. Allergy. 2008;63:284-291.
23. Smith RD. The relative sensitivity of willingness-topay and time-trade-off to changes in health status: An empirical investigation. Health Econ. 2001;10:487-497.
24. Ubel PA, Loewenstein G, Jepson C. Whose quality of life? A commentary exploring discrepancies between health state evaluations of patients and the general public. Qual Life Res. 2003;12:599-607.
25. Walker SM, Pajno GB, Lima MT, et al. Grass pollen immunotherapy for seasonal rhinitis and asthma: A randomized, controlled trial. J Allergy Clin Immunol. 2001;107:87-93.